Expression of PD-LI in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression

Expression of PD-LI in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression

Background: The PD-1/PD-L1 signaling axis is currently the most elucidated mechanism for tumor evasion of T-cell-mediated immunity. Nevertheless, few data are available regarding its impact on cervical cancer and the relationship with lymphocytic infiltrates. Methods: A retrospective assessment of a...

Full description

Saved in:
Bibliographic Details
Published in:Cancer management and research p. 4597
Main Authors: Grochot, Rafael M, Brollo, Janafna, Neto, Floriano Riva, Tregnago, Aline C, Scholze, Cassiano, Norris, Rui, Silva, Sargeele, Weschenfelder, Debora C, Reiriz, Andre B, Michelin, Lessandra, Pasqualotto, Fabio F
Format: Journal Article
Language:English
Published: Dove Medical Press Limited 01-05-2019
Subjects:
Analysis
Carcinoma
Cervical cancer
Development and progression
EDTA
Electronic records
Lymphocytes
T cells
Tumors
Brazil
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The PD-1/PD-L1 signaling axis is currently the most elucidated mechanism for tumor evasion of T-cell-mediated immunity. Nevertheless, few data are available regarding its impact on cervical cancer and the relationship with lymphocytic infiltrates. Methods: A retrospective assessment of all cases of cervical neoplasia treated in Caxias do Sul General Hospital, Brazil, between 2012 and 2016 was performed. Clinical and pathological data were collected from electronic records and analyzed. Original slides were independently reviewed by three pathologists to confirm diagnoses and to assess the immunohistochemical expression of PD-L1 and FoxP3 in tumor cells and lymphocytic infiltrates. Results: PD-L1 staining was present in 32.2% of the 59 cervical samples. Median overall survival time of the PD-L1-negative group was 47.8 months, a time point not yet reached by the PD-L1-positive group (p=0.968). Median progression-free survival was 24.3 months for PD-L1-negative and 11.5 months for PD-L1-positive patients (p=0.263). PD-L1 staining was found in 27.1% of the lymphocytic infiltrates, and survival analysis revealed no difference between PD-L1-positive and PD-L1-negative samples. There was no impact on survival related to FoxP3 staining in neither tumor samples nor lymphocytic infiltrates. Conclusion: Although the median progression-free survival times differed, the difference was not statistically significant. Our study corroborates the rationale that PD-L1 expression in cervical neoplasms has no impact on survival. PD-L1 expression in peritumoral lymphocytes revealed no impact on infiltration volume nor survival. Keywords: uterine cervical neoplasms, tumor-infiltrating lymphocytes, cancer, tumor microenvironment, survival
ISSN:1179-1322
1179-1322
DOI:10.2147/CMAR.S194597